BioCentury | Jan 4, 2019
Financial News
Cydan spins out rare endocrine company Tiburio with $31M, Ipsen compounds
...commercial milestones, plus royalties. Ceesay declined to disclose financial terms. Tiburio Therapeutics Inc., Cambridge, Mass.
Jennie Walters
TBR-065 (BIM-23B065)
TBR-760...
